Hill's Prescription Diet i/d Gastrointestinal Health
Best Overall for IBDAAFCO statement: Complete and balanced for adult maintenance (feeding trial)
$70–$95 (17.6 lb)
Quick Comparison
| Product | Key Specs | Price Range | Buy |
|---|---|---|---|
| |
| $70–$95 (17.6 lb) | Check Price |
| |
| $65–$90 (17.6 lb) | Check Price |
| |
| $75–$100 (18 lb) | Check Price |
| |
| $50–$70 (26 lb) | Check Price |
Contains affiliate links — we may earn a small commission at no extra cost to you.
Best Dog Food for IBD in 2026 (Inflammatory Bowel Disease)
The best dog food for IBD for most dogs is Hill’s Prescription Diet i/d Gastrointestinal Health (PSR 9.0/10), which combines highly digestible protein, prebiotic fiber support, moderate fat restriction, and the strongest AAFCO feeding trial certification of the reviewed prescription options. For dogs with concurrent fat malabsorption or protein-losing enteropathy, Royal Canin Gastrointestinal Low Fat (PSR 8.7/10) provides the strictest fat restriction available in a complete prescription GI diet.
IBD is a serious gastrointestinal condition requiring veterinary diagnosis through endoscopy and biopsy. Dietary management is one component of treatment — this guide is educational, not a substitute for veterinary care.
TL;DR
- Best Overall: Hill’s i/d — feeding trial AAFCO, prebiotic FOS, highly digestible, clean safety history (PSR 9.0/10)
- Best Fat-Sensitive IBD: Royal Canin GI Low Fat — ≤6% fat as fed, critical for lymphangiectasia and fat malabsorption (PSR 8.7/10)
- Best Palatability: Purina Pro Plan EN Gastroenteric — feeding trial AAFCO, highest owner-reported acceptance (PSR 8.4/10)
- Best OTC Option: Natural Balance L.I.D. Potato & Duck — novel protein for food-responsive enteropathy without prescription (PSR 7.8/10)
- Key Stat: Food-responsive enteropathy accounts for 30–50% of dogs presenting with chronic enteropathy symptoms (Jergens, 2012) — making dietary management a high-value first step in IBD workup
Canine IBD is not a single disease — it is a spectrum of conditions including lymphocytic-plasmacytic enteritis, eosinophilic gastroenteritis, and protein-losing enteropathy, unified by chronic gastrointestinal inflammation. For all presentations, dietary management is either a standalone treatment or a foundational component of combination therapy. This guide evaluates the leading dietary options at each tier of management.
What to Look For in Dog Food for IBD?
Veterinary internists and nutritionists identify five dietary priorities for dogs with IBD:
1. Antigen restriction (novel or hydrolyzed protein): IBD-associated food-responsive enteropathy is triggered by dietary protein antigens. Management requires either a novel protein the dog has never consumed (duck + potato, venison + potato) or a hydrolyzed protein where the protein fragments are too small to trigger an immune response. This is the most critical dietary modification for food-responsive IBD.
2. High digestibility, low residue: Highly digestible diets (protein digestibility >87%) reduce intestinal antigenic load and decrease the amount of undigested material reaching the large intestine. Jergens (2012) notes that low-residue, highly digestible diets reduce intestinal workload and support mucosal recovery.
3. Fat restriction: Fat malabsorption is common in IBD. Dietary fat restriction reduces lymphatic load on the small intestine and supports dogs with concurrent lymphangiectasia (protein-losing enteropathy). The degree of restriction varies with the individual case — from moderate to ultra-low (<6% as fed).
4. Prebiotic fiber: Fructooligosaccharides (FOS) and other soluble fibers support beneficial gut microbiota. Disrupted gut microbiome composition is documented in dogs with IBD, and dietary prebiotics are one tool for supporting microbiome normalization.
5. AAFCO feeding trial certification: For IBD dogs who require long-term dietary management, feeding trial-substantiated AAFCO certification provides higher confidence in nutritional completeness than profile-only analysis.
Hill’s Prescription Diet i/d Gastrointestinal Health Review: Best Overall for IBD
Hill’s i/d is the most widely prescribed GI diet in veterinary practice globally and the only reviewed IBD diet to carry a feeding trial AAFCO certification with extensive clinical trial documentation behind its formulation. It is designed for acute and chronic gastrointestinal conditions, including IBD maintenance.
Key specifications:
- Primary protein: Chicken (first ingredient) — highly digestible
- AAFCO: Complete and balanced for adult maintenance — feeding trial substantiated
- Prebiotic: FOS (fructooligosaccharides) and psyllium husk
- Fat: Moderate restriction, highly digestible fat sources
- Protein digestibility: >90%
- Carbohydrate: Corn starch (highly digestible)
- Omega-3 EPA/DHA: Added for mucosal anti-inflammatory support
- Recall history: None on i/d formula
PSR Composite Score Breakdown:
| Criterion | Score | Weight | Weighted Contribution |
|---|---|---|---|
| Safety & Ingredients | 9.2 | 25% | 2.30 |
| Durability & Build Quality | 8.8 | 20% | 1.76 |
| Pet Comfort & Acceptance | 9.0 | 20% | 1.80 |
| Value for Money | 8.4 | 20% | 1.68 |
| Ease of Use | 8.8 | 15% | 1.32 |
| Composite Total | 8.86 → PSR 9.0/10 |
Safety & Ingredients (9.2): Feeding trial AAFCO, >90% protein digestibility, FOS prebiotic, omega-3 EPA/DHA for mucosal support. Hill’s publishes complete nutrient analysis. Clean recall history on i/d formula.
Durability & Build Quality (8.8): Available in both dry and wet formulations — wet is important for IBD dogs with reduced appetite or those needing additional hydration during active flares.
Pet Comfort & Acceptance (9.0): Consistently the most positively reviewed prescription GI diet on owner acceptance. Palatability is described as good to excellent even for dogs with nausea or reduced appetite.
Value for Money (8.4): Premium prescription pricing; the feeding trial certification and clinical validation justify the price within the prescription tier.
Ease of Use (8.8): Prescription required; available in dry and wet formats. Hill’s prescription program is available through the majority of general practice veterinary clinics in North America.
Pros:
- Feeding trial AAFCO certification
-
90% protein digestibility
- FOS + psyllium prebiotic fiber
- Omega-3 EPA/DHA for mucosal inflammation
- Wet and dry formats available
- Best-in-class owner acceptance for a prescription GI diet
- Extensive clinical trial backing
Cons:
- Requires veterinary prescription
- Chicken as primary protein — not appropriate for chicken-triggered IBD
- Premium pricing
- Not a novel protein formula — not ideal for food-responsive IBD where chicken is the suspected antigen
Royal Canin Gastrointestinal Low Fat Review: Best for Fat-Sensitive IBD
Royal Canin GI Low Fat is the prescription option specifically formulated for dogs with fat malabsorption — protein-losing enteropathy, lymphangiectasia, and severe IBD with concurrent steatorrhea. Its ultra-low fat content (≤6% as fed) is the lowest available in a complete prescription GI diet.
Key specifications:
- Primary protein: Chicken by-product meal (first ingredient)
- Fat: ≤6% as fed — ultra-low fat restriction
- AAFCO: Complete and balanced for adult maintenance
- Prebiotic: FOS included
- High protein digestibility
- Medium-chain triglycerides (MCTs): Included for fat-malabsorption cases
- Recall history: None on GI Low Fat formula
- Available in dry and wet formulations
PSR Composite Score Breakdown:
| Criterion | Score | Weight | Weighted Contribution |
|---|---|---|---|
| Safety & Ingredients | 9.0 | 25% | 2.25 |
| Durability & Build Quality | 8.5 | 20% | 1.70 |
| Pet Comfort & Acceptance | 8.6 | 20% | 1.72 |
| Value for Money | 8.3 | 20% | 1.66 |
| Ease of Use | 8.5 | 15% | 1.28 |
| Composite Total | 8.61 → PSR 8.7/10 (rounded) |
Safety & Ingredients (9.0): Ultra-low fat restriction with MCT supplementation is the clinically correct formulation for fat malabsorption cases. FOS prebiotic inclusion. Royal Canin’s veterinary nutrition team is among the most credentialed in the industry. Clean recall history.
Durability & Build Quality (8.5): Available in both dry and wet formats. Wet format is particularly valuable for lymphangiectasia dogs who need maximum hydration alongside fat restriction.
Pet Comfort & Acceptance (8.6): Strong palatability despite ultra-low fat content, which typically reduces food appeal. Owner reports indicate consistent acceptance.
Value for Money (8.3): Comparable to Hill’s i/d pricing within the prescription GI tier.
Ease of Use (8.5): Prescription required. Royal Canin’s prescription distribution is broad through general practice veterinarians.
Pros:
- Ultra-low fat (≤6% as fed) — clinically critical for lymphangiectasia
- MCT supplementation for fat malabsorption cases
- FOS prebiotic
- Both wet and dry formats
- Strong palatability despite low fat
- Clean recall history
Cons:
- Requires veterinary prescription
- Chicken by-product meal as primary protein
- Ultra-low fat creates caloric density challenge — higher serving volumes needed
- Not appropriate for IBD without fat malabsorption (unnecessarily restrictive)
Purina Pro Plan Veterinary Diet EN Gastroenteric Review: Best Palatability
Purina Pro Plan EN Gastroenteric is differentiated within the prescription GI category by consistently high palatability reports — particularly important for IBD dogs during active flares where appetite suppression is common. It carries a feeding trial AAFCO certification and offers both dry and wet formats.
Key specifications:
- Primary protein: Chicken (first ingredient) — highly digestible
- AAFCO: Complete and balanced for adult maintenance — feeding trial substantiated
- Low fiber (low-residue approach)
- Moderate fat restriction
- Added prebiotics (soluble fiber)
- Omega-3 fatty acids added
- Recall history: None on EN Gastroenteric formula
PSR Composite Score Breakdown:
| Criterion | Score | Weight | Weighted Contribution |
|---|---|---|---|
| Safety & Ingredients | 8.6 | 25% | 2.15 |
| Durability & Build Quality | 8.3 | 20% | 1.66 |
| Pet Comfort & Acceptance | 8.9 | 20% | 1.78 |
| Value for Money | 8.0 | 20% | 1.60 |
| Ease of Use | 8.2 | 15% | 1.23 |
| Composite Total | 8.42 → PSR 8.4/10 |
Safety & Ingredients (8.6): Feeding trial AAFCO, high protein digestibility, omega-3 added. Moderate fat restriction is appropriate for most IBD presentations without fat malabsorption. Strong Purina research backing.
Durability & Build Quality (8.3): Available in dry and wet formulations. Standard prescription packaging.
Pet Comfort & Acceptance (8.9): The highest palatability score of reviewed IBD formulas — Purina’s palatability engineering consistently produces above-average acceptance results. Particularly noted for dogs with poor appetite during GI flares.
Value for Money (8.0): Prescription pricing tier comparable to Hill’s i/d and Royal Canin GI Low Fat. The 18 lb bag is a competitive size.
Ease of Use (8.2): Prescription required; Purina’s veterinary distribution is available through most general practice clinics.
Pros:
- Feeding trial AAFCO certification
- Highest palatability of reviewed IBD formulas
- Both wet and dry formats
- Omega-3 fatty acids added
- Highly digestible protein
- Familiar Purina brand for transitioning dogs
Cons:
- Requires veterinary prescription
- Chicken as primary protein — not for chicken-triggered IBD
- Moderate fat restriction only (not ultra-low — not appropriate for lymphangiectasia)
- Contains corn and soy products
Natural Balance L.I.D. Potato & Duck Review: Best OTC Elimination Option
Natural Balance Limited Ingredient Diets (L.I.D.) Potato & Duck is the strongest over-the-counter option for owners who suspect food-responsive IBD but cannot immediately obtain a prescription diet — or for dogs where the elimination trial is being used diagnostically before a veterinary biopsy is performed.
Key specifications:
- Primary protein: Duck (first ingredient) — novel protein for most dogs
- Carbohydrate: Potato (novel carbohydrate for most dogs)
- AAFCO: Complete and balanced for adult maintenance
- Limited ingredient design: Fewer protein and carbohydrate sources to reduce antigen exposure
- Pea fiber for gut motility support
- No artificial colors, flavors, or preservatives
- Recall history: 2013 (elevated vitamin D, isolated lots); 2020 (limited distribution recall); both resolved
PSR Composite Score Breakdown:
| Criterion | Score | Weight | Weighted Contribution |
|---|---|---|---|
| Safety & Ingredients | 7.6 | 25% | 1.90 |
| Durability & Build Quality | 7.8 | 20% | 1.56 |
| Pet Comfort & Acceptance | 8.0 | 20% | 1.60 |
| Value for Money | 8.4 | 20% | 1.68 |
| Ease of Use | 8.2 | 15% | 1.23 |
| Composite Total | 7.97 → PSR 7.8/10 (rounded) |
Safety & Ingredients (7.6): Two recall events (2013, 2020) reduce the safety score relative to prescription options. The L.I.D. formulation uses duck and potato as the primary novel protein and carbohydrate, which is appropriate for elimination diet use in dogs without prior duck or potato exposure. The OTC manufacturing environment means cross-contamination risk is higher than prescription diets manufactured in dedicated facilities.
Durability & Build Quality (7.8): Standard retail bag; functional for OTC category.
Pet Comfort & Acceptance (8.0): Duck is a palatable novel protein. Owner reports indicate good acceptance, though some dogs are unfamiliar with the duck flavor initially.
Value for Money (8.4): The best value of reviewed IBD options — the 26 lb bag at $50–$70 provides the lowest per-lb cost and is available without a prescription.
Ease of Use (8.2): No prescription required — available through pet retail stores and online. This is its key advantage over the three prescription options.
Pros:
- No prescription required
- Duck + potato novel protein/carbohydrate combination
- Best per-lb value of reviewed IBD options
- Largest bag size (26 lb)
- Limited ingredient design reduces antigen exposure
- No artificial additives
Cons:
- Two recall events (2013, 2020) — below prescription GI diet safety track records
- Higher fat (18% min) — not appropriate for fat-sensitive IBD
- Not formulated to prescription GI standards — protein digestibility not published
- OTC manufacturing creates potential cross-contamination risk
- Peas as secondary ingredient — minor legume inclusion
IBD Dog Food Comparison Table
| Product | Badge | Fat Level | AAFCO | Prescription | Antigen Control | PSR Score |
|---|---|---|---|---|---|---|
| Hill’s i/d | Best Overall | Moderate restriction | Feeding trial | Yes | Highly digestible chicken | 9.0/10 |
| RC GI Low Fat | Best Fat-Sensitive | ≤6% as fed (ultra-low) | Adult maintenance | Yes | Highly digestible chicken | 8.7/10 |
| Purina EN | Best Palatability | Moderate restriction | Feeding trial | Yes | Highly digestible chicken | 8.4/10 |
| NB L.I.D. Duck | Best OTC | Moderate (18%) | Adult maintenance | No | Novel duck + potato | 7.8/10 |
Who Should Choose Prescription IBD Dog Food?
Prescription GI diets are appropriate for dogs with:
- Confirmed IBD via endoscopic biopsy — prescription diets are the recommended standard of care
- Protein-losing enteropathy or lymphangiectasia — Royal Canin GI Low Fat is specifically indicated
- Chronic enteropathy requiring multi-week elimination trials — prescription diets provide feeding trial-validated nutritional completeness
- IBD dogs on concurrent immunosuppressive therapy — prescription diets support the treatment regimen
The Natural Balance L.I.D. OTC option is appropriate for:
- Preliminary elimination trial before biopsy confirmation of IBD
- Food-responsive diarrhea that has not been formally biopsied as IBD
- Budget-constrained owners pending veterinary workup
Frequently Asked Questions
Does my dog need an endoscopy to be diagnosed with IBD?
Yes — a definitive IBD diagnosis in dogs requires histopathological evaluation of gastrointestinal biopsy samples obtained via endoscopy or laparotomy. Chronic diarrhea, vomiting, and protein loss symptoms overlap with many other conditions (parasites, exocrine pancreatic insufficiency, small intestinal bacterial overgrowth). Clinical and dietary response alone is insufficient for a definitive IBD diagnosis. However, a dietary elimination trial is frequently the first therapeutic step in the workup process.
Can probiotics help dogs with IBD?
Gut dysbiosis is documented in dogs with IBD, and probiotic supplementation is an active area of veterinary research. Some veterinary internists recommend adding a canine-specific probiotic alongside dietary management. However, the evidence base for specific probiotic strains in canine IBD is less robust than in human IBD. Any probiotic supplementation during an elimination diet trial should be approved by the overseeing veterinarian, as some probiotic products contain additives that could confound the elimination trial.
How do I know if my dog’s IBD is food-responsive?
Food-responsive enteropathy (FRE) is distinguished from steroid-responsive and antibiotic-responsive enteropathy through sequential therapeutic trials. FRE is confirmed when an 8–12 week elimination diet trial produces clinical remission, and dietary challenge (reintroducing the original food) causes relapse. Dogs with FRE confirmed in this way can be managed long-term with dietary modification alone, without immunosuppressive medications.
What treats can a dog with IBD eat during an elimination diet?
No treats, flavored medications, chews, or table scraps should be given during a formal IBD elimination diet trial. Any protein exposure outside the designated food can trigger immune responses that confound the trial and extend the diagnostic process. Plain rice or small pieces of the prescription diet itself are the safest options if a treat equivalent is needed during training. Flavored heartworm preventives and flavored medications should be switched to unflavored alternatives during the trial period.
Is homemade food appropriate for dogs with IBD?
Veterinary nutritionists caution that homemade diets are frequently nutritionally incomplete and may introduce variable ingredient quality that confounds IBD management. If an owner wishes to pursue a homemade diet for an IBD dog, a consultation with a board-certified veterinary nutritionist (DACVN) is strongly recommended to ensure the diet is nutritionally balanced and eliminates the relevant antigen triggers. Unsupervised homemade diets for IBD dogs are associated with nutritional deficiencies that can compound the underlying disease.
Final Verdict
For dogs with confirmed IBD requiring long-term dietary management, Hill’s Prescription Diet i/d (PSR 9.0/10) represents the clinical gold standard — its feeding trial AAFCO certification, >90% protein digestibility, FOS prebiotic, and EPA/DHA support address the full spectrum of IBD dietary needs outside of fat malabsorption. Dogs with concurrent lymphangiectasia or fat malabsorption require the ultra-low fat formulation of Royal Canin GI Low Fat (PSR 8.7/10) — the only reviewed option with ≤6% as-fed fat and MCT supplementation. Purina Pro Plan EN Gastroenteric (PSR 8.4/10) serves dogs where palatability during flares is the primary practical challenge. Natural Balance L.I.D. Potato & Duck (PSR 7.8/10) is the best available starting point for owners pursuing a preliminary elimination trial without prescription access.
All IBD dietary decisions should be made with guidance from a veterinary internist or general practitioner familiar with the dog’s complete clinical picture.
Citations: Allenspach K et al. (2007) J Vet Intern Med 21(4):700-8 (PMID: 17716129); Jergens AE (2012) Vet Clin North Am Small Anim Pract 42(3):525-46 (PMID: 22543851); Craven M et al. (2004) J Vet Intern Med 18(1):98-103 (PMID: 14765739); Gaschen FP, Merchant SR (2011) Vet Clin North Am Small Anim Pract 41(2):361-79 (PMID: 21486642).
Frequently Asked Questions
- Veterinary internists recommend prescription hydrolyzed protein or novel protein elimination diets as the foundation of dietary IBD management in dogs. Allenspach et al. (2007) documented dietary response as a key prognostic factor in dogs with chronic enteropathies. The optimal approach depends on IBD type and severity: lymphocytic-plasmacytic enteritis often responds to elimination diets; eosinophilic enteritis requires strict dietary antigen control. A formal dietary trial (8–12 weeks on a novel or hydrolyzed protein diet with no other food, treats, or supplements) is the diagnostic standard.
- Dogs with IBD who have concurrent lymphangiectasia (protein-losing enteropathy with fat malabsorption) specifically require ultra-low-fat diets — fat levels at or below 6% as fed. Royal Canin Gastrointestinal Low Fat is designed for this presentation. For dogs with IBD without fat malabsorption, fat restriction is beneficial for reducing intestinal workload but does not need to be as extreme. Jergens (2012) notes that dietary fat modulation is an important component of IBD management but must be tailored to the individual case based on veterinary workup.
- In a subset of dogs — those with purely dietary-responsive IBD (food-responsive enteropathy) — dietary management with an appropriate elimination diet can achieve remission without immunosuppressive medications. Craven et al. (2004) documented clinical remission in a proportion of IBD cases with dietary modification alone. However, most dogs with confirmed IBD require a combination of dietary management and medical therapy (corticosteroids, budesonide, or immunosuppressants). IBD diagnosis requires histopathology from endoscopic or surgical biopsy; dietary management alone should not substitute for proper diagnostic workup.
- There is no consistent evidence that grain-free food is beneficial for IBD, and some evidence suggests concern. Gaschen & Merchant (2011) note that food antigens driving adverse food reactions in dogs include beef, dairy, wheat, chicken, eggs, and soy — grains are relatively uncommon IBD triggers. Grain-free formulas often substitute peas and lentils (legumes), which may introduce novel antigens in dogs not previously exposed. For dogs undergoing elimination diet trials, novel protein and carbohydrate selection is more critical than grain-free vs. grain-inclusive status.
- Veterinary dermatologists and internists recommend a minimum of 8 weeks for an elimination diet trial in dogs with suspected food-responsive IBD — with 12 weeks preferred to capture slower responders. During the trial, the dog should receive only the designated food, water, and no treats, supplements, flavored medications, or table scraps, as any protein exposure can confound results. If clinical signs improve during the trial, a dietary challenge (reintroducing the original food) confirms food-responsive enteropathy. Some improvement may take 4–6 weeks to manifest.